Salivary secretion and drug treatment in four 70-year-old Swedish cohorts during a period of 30 years

Gerodontology

Volumn 32, Issue 3, 2015, Pages 202-210

  Johanson, Cecilia N ^a   Österberg, Tor ^a   Lernfelt, Bodil ^a   Ekström, Jörgen ^a   Birkhed, Dowen ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

elderly; epidemiology; medication; population study; stimulated and unstimulated saliva.

Indexed keywords

ANTIDEPRESSANT AGENT; CARDIOVASCULAR AGENT; NEUROLEPTIC AGENT;

AGED; CHEMICALLY INDUCED; COHORT ANALYSIS; FEMALE; HUMAN; MALE; SALIVA; SECRETION (PROCESS); SWEDEN; XEROSTOMIA;

AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CARDIOVASCULAR AGENTS; COHORT STUDIES; FEMALE; HUMANS; MALE; SALIVA; SWEDEN; XEROSTOMIA;

EID: 84939570596     PISSN: 07340664     EISSN: 17412358     Source Type: Journal    
DOI: 10.1111/ger.12089     Document Type: Article

References (51)

1. Bulpitt CJ, Shipley MJ, Broughton PMG, Fletcher AE, Markowe HL, Marmot MG, et al,. The assessment of biological age: a report from the Department of Environment Study. Aging (Milano) 1994; 6: 181-91.
2. Vissink A, Spijkervet F, Amerongen A,. Aging and saliva: a review of the literature. Spec Care Dentist 1996; 16: 95-103.
3. Nagler RM,. Salivary glands and the aging process: mechanistic aspects, health-status and medicinal-efficacy monitoring. Biogerontology 2004; 5: 223-33.
4. Aps J, Martens L,. Review: the physiology of saliva and transfer of drugs into saliva. Forensic Sci Int 2005; 150: 119-31.
5. Ekström J, Khosravani N, Castagnola M, Messana I,. Saliva and the control of Its secretion. In:, Ekberg O, ed. Dysphagia, Medical Radiology. Diagnostic Imaging. Heidelberg: Springer-Verlag Berlin, 2012: 19-47.
6. Landahl S,. Drug treatment in 70-82-year-old persons. A longitudinal study. Acta Med Scand 1987; 221: 179-84.
7. Jylha M,. Ten-year change in the use of medical drugs among the elderly-a longitudinal study and cohort comparison. J Clin Epidemiol 1994; 47: 69-79.
8. Rumble RH, Morgan K,. Longitudinal trends in prescribing for elderly patients: two surveys four years apart. Br J Gen Pract 1994; 44: 571-5.
9. Woo J, Ho SC, Yuen YK, Lau J,. Drug use in an elderly Chinese population: prevalence and associated factors. Gerodontology 1995; 41: 98-108.
10. Nobili A, Tettamanti M, Frattura L, Spagnoli A, Ferraro L, Marrazzo E, et al,. Drug use by the elderly in Italy. Ann Pharmacother 1997; 31: 416-22.
11. Barat I, Andreasen F, Damsgaard EM,. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000; 56: 501-9.
12. Lernfelt B, Samuelsson O, Skoog I, Landahl S,. Changes in drug treatment in the elderly between 1971 and 2000. Eur J Clin Pharmacol 2003; 59: 637-44.
13. Junius-Walker U, Theile G, Hummers-Pradier E,. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract 2007; 24: 14-9.
14. Nederfors T,. Xerostomia and hyposalivation. Adv Dent Res 2000; 14: 48-56.
15. Sreebny L, Schwartz S,. A reference guide to drugs and dry mouth-2nd edition. Gerodontology 1997; 1: 33-47.
16. Flink H, Bergdahl M, Tegelberg Å, Rosenblad A, Lagerlöf F, Prevalence of hyposalivation in relation to general health, body mass index and remaining teeth in different age groups of adults. Community Dent Oral Epidemiol 2008; 36: 523-31.
17. Österberg T, Landahl S, Hedegård B,. Salivary flow, saliva, pH and buffering capacity in 70-year-old men and women. Correlation to dental health, dryness in the mouth, disease and drug treatment. J Oral Rehabil 1984; 11: 157-70.
18. Smidt D, Torpet LA, Nauntoft B, Heegaard KM, Pedersen AM,. Associations between labial and whole salivary flow rates, systematic diseases and medications in a sample of older people. Community Dent Oral Epidemiol 2010; 38: 422-35.
19. Smidt D, Torpet LA, Nauntoft B, Heegaard KM, Pedersen AM,. Associations between oral and ocular dryness, labial and whole salivary flow rates, systematic diseases and medications in a sample of older people. Community Dent Oral Epidemiol 2010; 39: 276-88.
20. Leal SC, Bittar J, Portugal A, Falcao DP, Fader J,. Medication in elderly people: its influence on salivary pattern, signs and symptoms of dry mouth. Gerodontology 2010; 27: 129-33.
21. Närhi TO, Kurki N, Ainamo A,. Saliva, salivary micro-organisms, and oral health in the home-dwelling old elderly-a five-year longitudinal study. J Dent Res 1999; 78 (10): 1640-6.
22. Ichikawa K, Sakuma S, Yoshihara A, Miyazaki H, Funayama S, Ito K, et al,. Relationship between the amount of saliva and medications in elderly individuals. Gerodontology 2011; 28: 16-20.
23. Thorselius I, Emilson CG, Österberg T,. Salivary conditions and drug consumption in older age groups of elderly Swedish individuals. Gerodontics 1988; 4: 66-70.
24. Nederfors T, Dahlöf C, Ericsson T, Tvetman S,. Effects of the antihypertensive drug captopril on human salivary secretion rate and composition. Eur J Oral Sci 1995; 103: 351-4.
25. Scelza MF, Silva DD, Ahiadzro NK, da Silva LE, Seelza P,. The influence of medication on salivary flow of the elderly: preliminary study. Gerodontology 2010; 27: 278-82.
26. Torpet LA, Kragelund C, Reibel J, Nauntofte B,. Oral adverse drug reactions to cardiovascular drugs. Crit Rev Oral Biol Med 2004 Jan 1; 15 (1): 28-46.
27. Friedlander AH, Norman DC,. Late-life depression: psychopathology, medical interventions, and dental implications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 404-12.
28. Scully C,. Drug effects on salivary glands: dry mouth. Oral Dis 2003; 9: 165-76.
29. Mese H, Matsuo R,. Salivary secretion, taste and hyposalivation. J Oral Rehabil 2007; 34: 711-23.
30. Wolff A, Zuk-Paz L, Kaplan I,. Major salivary gland output differs between users and non-users of specific medication categories. Gerodontology 2008; 25: 210-6.
31. Johansson A-K, Johansson A, Unell L, Ekbäck G, Ordell S, Carlsson GE,. Self-reported dry mouth in Swedish population samples aged 50, 65 and 75 years. Gerodontology 2012; 29: e107-15.
32. Österberg T, Birkhed D, Johanson C, Svanborg A, Longitudinal study of stimulated whole saliva in an elderly population. Scand J Dent Res 1992; 100: 340-5.
33. Steen B, Djurfeldt H,. The gerontological and geriatric population studies in Gothenburg Sweden. Z Gerontol 1993; 26: 163-9.
34. Rinder L, Roupe S, Steen B, Svanborg A,. 70-year-old people in Gothenburg. A population study in an industrialized Swedish city. I. General design of the study. Acta Med Scand 1975; 198: 397-407.
35. Eriksson BG, Mellström D, Svanberg A,. Medical-social intervention in a 70-year-old Swedish population. Compr Gerontol C 1987; 1: 49-56.
36. Österberg T, Johanson C, Sundh V, Steen B, Birkhed D,. Secular trends of dental status in five 70-year-old cohorts between 1971 and 2001. Community Dent Oral Epidemiol 2006; 34: 446-54.
37. Österberg T, Hedegård B, Säther G,. Variation in dental health in 70-year old men and women in Gothenburg, Sweden. A cross-sectional epidemiological study including longitudinal and cohort effects. Swed Dent J 1983; 7: 29-48.
38. Johanson CN, Österberg T, Steen B, Birkhed D,. Prevalence and incidence of dental caries and related risk factors in 70- to 76-year-olds. Acta Odontol Scand 2009; 67: 304-12.
39. Ericsson Y, Hardwick L,. Individual diagnosis, prognosis and counselling for caries prevention. Caries Res 1978; 12 (Suppl 1): 94-102.
40. Nordic statistics on Medicines 1993-1995. NLN Publication No.43. Nordiska Läkemedelsnämnden, Uppsala, Sweden: Nordic Council on Medicines, 1997.
41. Ronnin M, Blix HS, Harbo BT, Strom H,. Different versions of the anatomical therapeutic chemical classification system and the defined daily dose-are drug utilisation data comparable? Eur J Clin Pharmacol 2000; 56: 723-7.
42. Svanborg A,. 70-year-old people in Gothenburg. A population study in an industrialized Swedish City. II. General presentation of social and medical condition. Acta Med Scand 1977; 611: 5-37.
43. National Board of Health and Welfare. The quality of drug treatment in the elderly (kvaliteten på läkemedelsanvändning hos äldre. Socialstyrelsen följer upp och utvärderar). Report 2000; 2000: 8.
44. Närhi TO,. Salivary secretion and use of medicines in the elderly. Tandläkartidningen 2001; 93 (2): 12-8.
45. Flink H, Tegelberg Å, Lagerlöf F,. Influence of the time of measurement of unstimulated human whole saliva on the diagnosis of hyposalivation. Arch Oral Biol 2005; 50: 553-9.
46. Godman LS, Gilmans A, Hardman JG, Goodman Gilman A, Limbird LE,. Goodman & Gilman's. The Pharmacological Basis of Therapeutics. 9th Edition. New York: McGraw-Hill. 1996.
47. Ekström J, Malmberg L,. Beta 1-adrenoceptor mediated salivary gland enlargement in the rat. Experientia 1984; 40 (8): 862-3.
48. Carlsöö B, Danielsson A, Henriksson R, Idahl LA,. Characterization of the rat parotid beta-adrenoceptor. Br J Pharmacol 1981; 72 (2): 271-6.
49. Jensen JL, Brodin P, Berg T, Aars H,. Parotid secretion of fluid, amylase and kallikrein during reflex stimulation under normal conditions and after acute administration of autonomic blocking agents in man. Acta Physiol Scand 1991; 143: 321-9.
50. 1-selective antagonist metoprolol in a hypertensive patient population. Eur J Oral Sci 1996; 104: 262-8.
51. Fitzgerald JD,. β-Adrenoceptor antagonists. In:, van Zwieten PA, ed. Handbook of Hypertension. Vol. 3. Pharmacology of Antihypertensive Drugs. Philadelphia: Elsevier: 1984: 249-306.